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Pediatric Dupuytren’s disease: case report and review
of the literature
Monique A. Gary and Rodrigo Santamarina
Dupuytren’s disease (DD) is a rare entity in the pediatric
population, especially in children younger than 10 years
of age. We report the case of a 6-year-old boy with
contracture and a left-hand nodule that was excised and
histologically confirmed to be Dupuytren’s. Although there
are several causes of flexion contracture of the fingers in
children, delayed diagnosis of DD can result in debilitating
disease and therefore should be an early consideration
when evaluating children with suspicious physical exam
findings with or without symptomatic contracture,
especially in the setting of a strong family history.
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Introduction
Classically considered a disease of adult onset, Dupuyt-
ren’s disease (DD) in the pediatric population is rare,
especially in children younger than 10 years of age. In this
population, the initial assessment may be performed by
pediatricians alone, and the differential diagnosis for
flexure contracture of the hand is variable, with DD often
a late consideration. We report the case of a 6-year-old
boy with symptomatic contracture and a left-hand nodule
histologically confirmed to be Dupuytren’s. Although
there may be several causes of palmar nodularity and
flexion contracture in children, the aim of this study is to
highlight the importance of early consideration of DD in
the setting of contracture, especially when a familial
association is elicited. Further, review of the current
literature of the natural history and progression of DD
is presented, and current management is discussed.
Case report
A 6-year-old boy was brought for evaluation by his
grandmother after 3 months of increasing pain upon
gripping objects, with no history of trauma. On examina-
tion, there was a firm, palpable nodule on the palmar
aspect of the ring finger. While obtaining a detailed
history, it was found that the family was of Nordic
descent, and the grandmother was noted to have a
Dupuytren’s nodule on her hand in the same location
(Fig. 1). The boy was subsequently taken to the operating
room, where a Bruner incision was made on the palmar
aspect of the ring finger along the ulnar border.
A localized palmar fasciectomy was performed (Fig. 2).
Histopathologic evaluation indicated fibromatosis consis-
tent with Dupuytren’s contracture (Fig. 3a–c). The
patient had an uneventful postoperative course. At
the 6-month follow-up, he had regained full function of
the affected hand, with no signs of recurrence.
Discussion
DD is a fibroproliferative disorder of autosomal dominant
inheritance. The disease causes a fixed flexion contrac-
ture of the hand; that is, the fingers are bent toward the
palm and cannot be fully extended. In general, the
disease is progressive and insidious, first manifested by
painless thickening of the involved tendon progressing to
hard nodule formation on the palmar fascia, which is
ultimately replaced by a tendon-like fibrous cord result-
ing in contracture [1]. The fourth and fifth digits are
most commonly affected. Risk factors for development of
the disease include Northern European descent, family
history, diabetes mellitus, and sex. However, after 80
years of age, the occurrence is equal in both sexes [2–4].
About 10% of patients with DD also have Peyronie
disease (penile fibromatosis). Environmental and other
epigenetic factors implicated in the epidemiology of this
contracture remain an area of current investigation [5].
There are three overlapping phases in the development
of DD, which include a proliferative stage, an involutional
stage, and a residual stage [1]. Early DD is histologically
hallmarked by hyperplasia and focal nodularity of the
fascia. Enhanced, disorganized fibroblast proliferation
with increased vascularity is pathognomonic for this
proliferative stage. The involutional stage is characterized
by the early formation of contracture as the number of
myofibroblasts decreases and nodules become smaller,
but more organized along the longitudinal axes of the
hand. The residual stage shows joint flexion contracture
with disappearance of nodules and the presence of
thickened, fibrous cords. This classification, first de-
scribed by Luck [1], is widely used in research, but is less
useful in clinical practice among surgeons. In general, the
physical exam may indicate a wide range of findings,
depending on the timing of diagnosis.
Clinical assessment incorporates a thorough assessment
of patient and family history, observed physical findings,
measurement of contracture deformity, and a positive
Hueston tabletop test [6] as part of the comprehensive
diathesis. Whereas early DD may be manifested by
painless cords, nodularity skin blanching, and atrophic
pitting [7], advanced disease is characterized by prominent,
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painful cords, contracture of the metacarpophalangeal joint
and proximal interphalangeal joint joints with secondary
deformity (Boutonniere and swan neck deformities), and
the presence of Garrod’s nodes (tender knuckle pads) [8].
Plantar fascia involvement (Ledderhose disease) is also
an indicator of severe disease [8]. Routine diagnostic
imaging is not indicated in the workup of this disease.
However, when the diagnosis is less certain, MRI,
computed tomography, and ultrasound have been used,
with varying degrees of success [9]. Ultrasound may
visualize hypertrophy of the palmar fascia and is
particularly useful to localize nodules for intralesional
injection therapy.
Staging for DD follows the grading system first estab-
lished by Tubiana [10]. Each stage is determined by the
total passive extension deficit or angle of contracture
deformity present on physical exam (stages 1–4). The
scoring system also takes into account the earliest
presentation of DD, which contains neither nodule nor
functional deficit (stage 0), and the presence of nodule
alone, without contracture deformity (stage N). Mod-
ifications to this staging system have been proposed and
staging has been revised to correlate the severity of
symptoms with the angle of contracture and joint
involvement [11]. The decision to perform a surgical
intervention is informed by the degree of contracture
(stage), failure of medical therapy, and, ultimately,
functional status of the hand – progressive weakness,
pain, and functional decline. An overview of the physical
findings, staging, and treatment strategies is summarized
in Fig. 4.
Although surgery remains the treatment of choice for DD
in both children and adults, formal guidelines for surgical
intervention are yet to be established. Treatment may
include percutaneous fasciotomy (needle aponeurotomy)
for early disease with minimal contracture, fasciectomy
(limited, segmental or radical), and dermofasciectomy
that removes the entire diseased fascia, cord, nodule, and
overlying skin, with graft repair of the resultant
defect [7,12,13]. Needle aponeurotomy has shown
efficacy in patients with well-defined cords and is
valuable as an alternative for patients in whom surgery
is contraindicated, although recurrence rates can be as
high as 50% [8,12]. Limited (selective) fasciectomy is
performed under regional or general anesthesia, where
diseased cord and fascia alone are excised [12]. Recently,
the 5-year follow-up results from a randomized-controlled
clinical trial comparing percutaneous needle fasciotomy
and limited fasciectomy have been reported [14]. Recur-
rence rates were significantly higher in the limited
fasciectomy group; however, time to recurrence was
earlier in the needle fasciotomy cohort.
Nonsurgical options for the management of DD have
been reviewed [15]. Reported modalities include ob-
servation (for stage N only), physical therapy, splinting,
radiation, dimethylsulfoxide, vitamin E cream, ultrasound
therapy, and enzymatic (collagenase) and corticosteroid
injections [16–18]. Many experimental agents are being
investigated, including 5-fluorouracil, botulinum toxin,
immunomodulators, matrix metalloproteinase inhibitors,
and hyperbaric oxygen therapy, for the effective treat-
ment of DD [19–23]. To date, the safety and efficacy of
nonsurgical therapies have not been validated in the
pediatric population.
Despite its rarity, pediatric DD is not a new entity.
In 1832, Baron Guillaume Dupuytren, a French anatomist
and surgeon, first identified a 6-year-old boy with a
permanent contracture of the ring and little fingers. This
condition was subsequently known as ‘Morbus Dupuyt-
ren’, ‘Dupuytren’s disease,’ or ‘Palmar fibromatosis’ [24].
The diagnosis was made without histological confirma-
tion. The first histologically diagnosed pediatric case was
in 1954 by Goetzee and Williams [25], who identified
Fig. 2
Intraoperative photograph of the Bruner incision and excised lesion.
Fig. 1
The nodule present on the hand of both the patient (right) and his
grandmother (left).
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a 14-year-old boy with flexion contractures of the ring and
little fingers. Since 1832, there have been fewer than 10
published cases of histologically proven DD in children
younger than 10 years of age. The youngest patients diag-
nosed with confirmed DD were two 6-month-old infants,
both treated successfully with surgical excision [26,27].
Fibroproliferative conditions other than DD are more
commonly identified as the cause of pediatric contrac-
ture. The differential diagnosis includes infantile digital
fibromatosis, camptodactyly, congenital ulnar drift, burns,
infantile fibrosarcoma and calcifying aponeurotic fibro-
mas, and more. Misdiagnosis has been reported (27), with
debilitating consequences. Early consideration, in-depth
assessment of history, and accurate diagnosis are essen-
tial; pathological evaluation of the specimen should
always be performed with the goal of ruling out
malignancy and confirming the diagnosis of DD among
a broad differential. Diagnosis of the disease in childhood
presents unique opportunities for long-term follow-up of
disease recurrence and may provide further insight into
the pathophysiology of this disease process.
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